Chinese markets recovered today, Ganfeng up 6.6%. Generally bodes well for trading tomorrow as long as the US holds up tonight. Feeling fairly confident. GLTA.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress